Search Results - "Génot, J. Y."

Refine Results
  1. 1

    Late psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study by Joly, F, Henry-Amar, M, Arveux, P, Reman, O, Tanguy, A, Peny, A M, Lebailly, P, Macé-Lesec'h, J, Vié, B, Génot, J Y, Busson, A, Troussard, X, Leporrier, M

    Published in Journal of clinical oncology (01-09-1996)
    “…To evaluate late psychosocial sequelae in long-term survivors of Hodgkin's disease (HD) in the population of Calvados, France. Ninety-three patients issued…”
    Get more information
    Journal Article
  2. 2

    Delayed adjuvant tamoxifen: Ten-year results of a collaborative randomized controlled trial in early breast cancer (TAM-02 trial) by Delozier, T., Switsers, O., Génot, J. Y., Ollivier, J. M., Héry, M., Namer, M., Fresney, M., Kerbrat, P., Veyret, C., de Lafontan, B., Janvier, M., Macé-Lesech, J.

    Published in Annals of oncology (01-05-2000)
    “…Aim: Immediate adjuvant tamoxifen reduces disease recurrence and improves survival in patients with early breast cancer. However, is it too late to administer…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy by Delcambre, C, Reman, O, Henry-Amar, M, Peny, A M, Macro, M, Cheze, S, Génot, J Y, Tanguy, A, Switsers, O, Van, H L, Couëtte, J E, Leporrier, M, Bardet, S

    Published in European journal of nuclear medicine (01-02-2000)
    “…The clinical impact of gallium-67 scintigraphy before and after therapy for lymphoma remains controversial. The aims of this study were: (1) to compare the…”
    Get full text
    Journal Article
  5. 5

    Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer by Chevallier, B, Chollet, P, Merrouche, Y, Roche, H, Fumoleau, P, Kerbrat, P, Genot, J Y, Fargeot, P, Olivier, J P, Fizames, C

    Published in Journal of clinical oncology (01-07-1995)
    “…To compare the efficacy and safety of recombinant human granulocyte colony-stimulating factor (rHuG-CSF) versus its inert vehicle in patients with unilateral…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Espace de parole en prévention du syndrome de burnout : deux ans d’expérience au sein de l’Association des jeunes oncologues bas-normands (Ajon) by Vanbockstael, J., Noal, S., Brachet, P. -E., Degrendel-Courtecuisse, A. -C., Geffrelot, J., Coquan, E., Pernin, V., Pascal, P., Genot, J. -Y., Do, P., Machavoine, J. -L., Joly, F., Lheureux, S.

    Published in Psycho-oncologie (01-06-2011)
    “…Résumé La souffrance des médecins, notamment celle des internes, reste peu abordée bien que le syndrome de burnout soit une réalité. L’Association des jeunes…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Myelodysplasia and leukaemia related to chemotherapy and/or radiotherapy--a haematological study of 13 cases. Value of macrocytosis as an early sign of bone marrow injury by Dohy, H, Genot, J Y, Imbert, M, D'Agay, M F, Sultan, C

    Published in Clinical and laboratory haematology (01-01-1980)
    “…Clinical and haematological features of 13 patients with secondary myelodysplastic syndromes (MDS) were studied, MDS developed subsequent to chemotherapy…”
    Get more information
    Journal Article
  11. 11

    Hematologic and cytogenetic study of two cases of acute leukemia associated with breast cancer by Smadja, N, Krulik, M, Genot, J Y, Audebert, A A, Debray, J

    Published in Cancer genetics and cytogenetics (01-07-1983)
    “…The authors present two cases of patients with breast cancer with lymph node extension and who both had surgery. As a pancytopenia with hypercellular bone…”
    Get more information
    Journal Article
  12. 12
  13. 13

    What can be now expected of the determination of estrogen and progesterone receptors in the treatment of breast cancers by Goussard, J, Génot, J Y

    Published in Bulletin du cancer (01-01-1994)
    “…Since the first published correlations around the years 1975 between estrogen and progesterone receptors and response to hormone therapy, numerous data have…”
    Get more information
    Journal Article
  14. 14

    Tamoxifen adjuvant delays early breast cancer. Results of a cooperative randomized trial by Delozier, T, Switsers, O, Génot, J Y, Ollivier, J M, Héry, M, Namer, M, Frenay, M, Kerbrat, P, Julien, J P, Naja, A, Janvier, M, Macé-Lesec'h, J

    Published in Bulletin du cancer (01-01-1997)
    “…Adjuvant tamoxifen (TAM) has been proved to reduce recurrence and mortality in early breast cancer, nevertheless many patients did not receive TAM as adjuvant…”
    Get full text
    Journal Article
  15. 15

    Acute leukemia associated with breast cancer (author's transl) by Krulik, M, Smadja, N, Genot, J Y, Audebert, A A, Canuel, C, Debray, J

    “…Two cases of acute leukemia in patients with breast cancer are reported. In the first patient, erythroleukemia occurred three years after breast cancer was…”
    Get more information
    Journal Article
  16. 16

    High grade primary breast lymphoma : is it a different clinical entity? by FRUCHART, Christophe, DENOUX, Yves, CHASLE, Jacques, PENY, Anne Marie, BOUTE, Veronique, OLLIVIER, Jean Michel, GENOT, Jean Yves, MICHELS, Jean-Jacques

    Published in Breast cancer research and treatment (01-10-2005)
    “…Primary lymphoma of the breast (PBL) is a rare neoplasm, its outcome remains unclear compared to other lymphomas. We performed a retrospective study of 19…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Ten novel Diamond-Blackfan anemia mutations and three polymorphisms within the rps19 gene by Proust, Alexis, Da Costa, Lydie, Rince, Patricia, Landois, Anaely, Tamary, Hannah, Zaizov, Rina, Tchernia, Gil, Delaunay, Jean

    “…A total of 25% of patients presenting with Diamond-Blackfan anemia (DBA) carry mutations in the rps19 gene, which encodes protein RPS19 of the small ribosomal…”
    Get more information
    Journal Article
  19. 19

    First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study by Allouache, Djelila, Gawande, Sulochana R, Tubiana-Hulin, Michele, Tubiana-Mathieu, Nicole, Piperno-Neumann, Sophie, Mefti, Fawzia, Bozec, Laurence, Genot, Jean-Yves

    Published in BMC cancer (29-11-2005)
    “…This phase II study evaluated the efficacy and safety of gemcitabine (G) plus paclitaxel (T) as first-line therapy in recurrent or metastatic breast cancer…”
    Get full text
    Journal Article
  20. 20

    Abnormality of chromosome number 1 in 3 cases of acute transformation of chronic myeloid leukemia by Smadja, N, Krulik, M, Génot, J Y, Audebert, A A, Debray, J

    “…The authors report three cases of Ph1-positive chronic myelogenous leukemia (CML) with chromosome no 1 abnormalities. Such abnormalities have seldom been…”
    Get more information
    Journal Article